Brief: Clene Reports Significant Improvement In Vision And Cognition With Cnm-Au8 Treatment

Clene

08/01/2024 14:14

Jan 8 (Reuters) - Clene Inc.  CLNN.O :
    * CLENE INC.- REPORTS SIGNIFICANT IMPROVEMENT IN VISION AND
COGNITION WITH CNM-AU8 TREATMENT IN VISIONARY-MS TRIAL LONG-TERM
OPEN LABEL EXTENSION
    * CLENE- TREATMENT WAS WELL-TOLERATED, WITHOUT A SINGLE
SERIOUS
ADVERSE EVENT ATTRIBUTED TO CNM-AU8 AND NO SIGNIFICANT SAFETY
FINDINGS REPORTED

Further company coverage:  CLNN.O 

 ((Reuters.Briefs@thomsonreuters.com;))